80 results
Page 3 of 4
6-K
EX-99.1
yx2xjagcq2ayfuwlf ql
28 May 20
Report of Foreign Private Issuer
9:25am
6-K
EX-99.1
hgleyffm 1bxc7v5
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
mgklg0jhaioabuy9uo
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
wd1iathi0uf u16i6
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-1.1
atd7t qmw
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
7emwyv8
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
dk7h9 q3nv1qcg
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
u5813 w90hbo3
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
849kjnbm9jerznh4
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
c7sn8
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.2
bat36cyle 338
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
489kf587me 2tdp
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
424B3
feoqrf vbg405we
10 Jul 19
Prospectus supplement
8:18am
F-3
rbndxtxk 7w1v
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
boq50
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.2
2hwvsfwogwiku
20 May 19
Condensed Consolidated Financial Statements
4:15pm